UnitedHealth Group Incorporated (NYSE:UNH) is Marks Group Wealth Management Inc’s 6th Largest Position

Marks Group Wealth Management Inc increased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 2.4% during the 4th quarter, Holdings Channel reports. The firm owned 31,226 shares of the healthcare conglomerate’s stock after acquiring an additional 720 shares during the quarter. UnitedHealth Group comprises approximately 1.6% of Marks Group Wealth Management Inc’s investment portfolio, making the stock its 6th largest holding. Marks Group Wealth Management Inc’s holdings in UnitedHealth Group were worth $15,796,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in the company. Davidson Capital Management Inc. boosted its stake in shares of UnitedHealth Group by 5.2% during the fourth quarter. Davidson Capital Management Inc. now owns 5,876 shares of the healthcare conglomerate’s stock valued at $2,972,000 after purchasing an additional 289 shares in the last quarter. Jmac Enterprises LLC increased its holdings in shares of UnitedHealth Group by 6.2% in the 4th quarter. Jmac Enterprises LLC now owns 874 shares of the healthcare conglomerate’s stock valued at $442,000 after acquiring an additional 51 shares during the period. Gladstone Institutional Advisory LLC boosted its position in UnitedHealth Group by 1.3% during the fourth quarter. Gladstone Institutional Advisory LLC now owns 13,863 shares of the healthcare conglomerate’s stock valued at $7,013,000 after purchasing an additional 175 shares in the last quarter. Perissos Private Wealth Management LLC bought a new position in UnitedHealth Group in the fourth quarter worth about $259,000. Finally, Capital Advisors Inc. OK grew its position in shares of UnitedHealth Group by 13.8% in the 4th quarter. Capital Advisors Inc. OK now owns 75,974 shares of the healthcare conglomerate’s stock worth $38,432,000 after buying an additional 9,197 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $533.99 on Wednesday. The firm’s 50 day simple moving average is $527.67 and its 200-day simple moving average is $564.22. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The stock has a market capitalization of $491.42 billion, a price-to-earnings ratio of 34.45, a PEG ratio of 1.45 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period last year, the firm earned $5.83 EPS. Analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Insider Activity at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.33% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the stock. Deutsche Bank Aktiengesellschaft raised their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. Piper Sandler reduced their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. Wells Fargo & Company dropped their price target on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. UBS Group lowered their target price on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Finally, Morgan Stanley lowered their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. One analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.